Cell-Based Assays for High-Throughput Screening

Cell-based assays represent approximately half of all high-throughput screens currently performed. Here, we review in brief the history and status of high-throughput screening (HTS), and summarize some of the challenges and benefits associated with the use of cell-based assays in HTS. Approaches for successful experimental design and execution of cell-based screens are introduced, including strategies for assay development, implementation of primary and secondary screens, and target identification. In doing so, we hope to provide a comprehensive review of the cell-based HTS process and an introduction to the methodologies and techniques used.

[1]  Alois Jungbauer,et al.  GFP-reporter for a high throughput assay to monitor estrogenic compounds. , 2005, Journal of biochemical and biophysical methods.

[2]  Fred Schaufele,et al.  The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Raikhel,et al.  Chemical genomics approaches in plant biology. , 2009, Methods in molecular biology.

[4]  Eric D Brown,et al.  High-throughput screening of model bacteria. , 2009, Methods in molecular biology.

[5]  J. White,et al.  Synergistic activation of transcription by the human estrogen receptor bound to tandem responsive elements. , 1990, The EMBO journal.

[6]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Vladimir Makarenkov,et al.  Using Clustering Techniques to Improve Hit Selection in High-Throughput Screening , 2006, Journal of biomolecular screening.

[8]  L. Zon,et al.  In vivo drug discovery in the zebrafish , 2005, Nature Reviews Drug Discovery.

[9]  A. Goffeau,et al.  The pleitropic drug ABC transporters from Saccharomyces cerevisiae. , 2001, Journal of molecular microbiology and biotechnology.

[10]  Vincent J. Dupriez,et al.  Adaptation of Aequorin Functional Assay to High Throughput Screening , 2002, Journal of biomolecular screening.

[11]  N. Kley,et al.  Chemical dimerizers and three-hybrid systems: scanning the proteome for targets of organic small molecules. , 2004, Chemistry & biology.

[12]  Guido Jach,et al.  An improved mRFP1 adds red to bimolecular fluorescence complementation , 2006, Nature Methods.

[13]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[14]  David S. Carter,et al.  Whole-organism screening: plants. , 2009, Methods in molecular biology.

[15]  Attila Tóth,et al.  A screen for genes required for meiosis and spore formation based on whole-genome expression , 2001, Current Biology.

[16]  Peter Buckel,et al.  High-throughput Functional Genomics Identifies Genes That Ameliorate Toxicity Due to Oxidative Stress in Neuronal HT-22 Cells , 2004, Molecular & Cellular Proteomics.

[17]  L. Naylor,et al.  Development of a Generic Dual-Reporter Gene Assay for Screening G-Protein-Coupled Receptors , 2005, Journal of biomolecular screening.

[18]  Hendrik Luesch,et al.  Towards high-throughput characterization of small molecule mechanisms of action. , 2006, Molecular bioSystems.

[19]  S. Cutler,et al.  Random GFP::cDNA fusions enable visualization of subcellular structures in cells of Arabidopsis at a high frequency. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. Archer,et al.  Modulating molecular chaperone Hsp90 functions through reversible acetylation. , 2005, Trends in cell biology.

[21]  Gregory J. Parker,et al.  Development of High Throughput Screening Assays Using Fluorescence Polarization: Nuclear Receptor-Ligand-Binding and Kinase/Phosphatase Assays , 2000, Journal of biomolecular screening.

[22]  Y. Yarden,et al.  Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. , 2000, Advances in cancer research.

[23]  Yung Hou Wong,et al.  Chimeric and Promiscuous G Proteins in Drug Discovery and the Deorphanization of GPCRs , 2005 .

[24]  Stuart L Schreiber,et al.  Small molecules: the missing link in the central dogma , 2005, Nature chemical biology.

[25]  Kenneth A. Giuliano,et al.  High content screening : a powerful approach to systems cell biology and drug discovery , 2007 .

[26]  Ian Collins,et al.  Identification of Small-Molecule Inhibitors of Protein Kinase B (PKB/AKT) in an AlphaScreen™ High-Throughput Screen , 2006, Journal of biomolecular screening.

[27]  P. Cleveland,et al.  Nanoliter dispensing for uHTS using pin tools. , 2005, Assay and drug development technologies.

[28]  Marc Parmentier,et al.  Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. , 2006, Cytokine & growth factor reviews.

[29]  Albert Gough,et al.  High-Content Screening: A New Approach to Easing Key Bottlenecks in the Drug Discovery Process , 1997 .

[30]  Anne E Carpenter,et al.  CellProfiler: free, versatile software for automated biological image analysis. , 2007, BioTechniques.

[31]  Konstantin V. Balakin and Nikolay P. Savchuk Computational Methods for Analysis of High-Throughput Screening Data , 2006 .

[32]  Virginia W Cornish,et al.  Selective chemical labeling of proteins in living cells. , 2005, Current opinion in chemical biology.

[33]  D. Speicher,et al.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A. , 1984, Science.

[34]  Stuart L Schreiber,et al.  Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis. , 2003, Journal of the American Chemical Society.

[35]  P. Fernandes,et al.  Technological advances in high-throughput screening. , 1998, Current opinion in chemical biology.

[36]  Robert A. Copeland,et al.  Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis , 1996 .

[37]  Jie Hu,et al.  Technological Advances in High-Throughput Screening , 2004, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[38]  Tudor I. Oprea,et al.  Integration of Virtual Screening with High-Throughput Flow Cytometry to Identify Novel Small Molecule Formylpeptide Receptor Antagonistss⃞ , 2005, Molecular Pharmacology.

[39]  K. Matsushima,et al.  Properties of the novel proinflammatory supergene "intercrine" cytokine family. , 1991, Annual review of immunology.

[40]  Trevor C. Y. Kwok,et al.  A small-molecule screen in C. elegans yields a new calcium channel antagonist , 2006, Nature.

[41]  Andreas Sewing,et al.  Development and Automation of a 384-Well Cell Fusion Assay to Identify Inhibitors of CCR5/CD4-Mediated HIV Virus Entry , 2004, Journal of biomolecular screening.

[42]  Bonnie J. Hanson Multiplexing Fluo-4 NW and a GeneBLAzer® Transcriptional Assay for High-Throughput Screening of G-Protein-Coupled Receptors , 2006, Journal of biomolecular screening.

[43]  L. Mosyak,et al.  Development of a fluorescence polarization assay to screen for inhibitors of the FtsZ/ZipA interaction. , 2003, Analytical biochemistry.

[44]  Robert Nadon,et al.  HTS-Corrector: software for the statistical analysis and correction of experimental high-throughput screening data , 2006, Bioinform..

[45]  Anne E Carpenter,et al.  A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen , 2006, Cell.

[46]  U Neumann,et al.  GFP is the way to glow: bioimaging of the plant endomembrane system , 2004, Journal of microscopy.

[47]  M. Hung,et al.  Overexpression of ErbB2 in cancer and ErbB2-targeting strategies , 2000, Oncogene.

[48]  Kell,et al.  Screensavers: trends in high-throughput analysis. , 1999, Trends in biotechnology.

[49]  Kevin R. Oldenburg,et al.  High Throughput Quantitation of cAMP Production Mediated by Activation of Seven Transmembrane Domain Receptors , 1999, Journal of biomolecular screening.

[50]  B. Shoichet,et al.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.

[51]  E. Butcher Can cell systems biology rescue drug discovery? , 2005, Nature Reviews Drug Discovery.

[52]  Bruce S Edwards,et al.  Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform , 2006, Nature Protocols.

[53]  T. Hayano,et al.  Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin , 1989, Nature.

[54]  Lei Wu,et al.  Ion-channel assay technologies: quo vadis? , 2001, Drug discovery today.

[55]  Philip M. Murphy,et al.  Cutting Edge: The Neurotoxic Prion Peptide Fragment PrP106–126 Is a Chemotactic Agonist for the G Protein-Coupled Receptor Formyl Peptide Receptor-Like 11 2 , 2001, The Journal of Immunology.

[56]  D. Sabatini,et al.  Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Lani F. Wu,et al.  Multidimensional Drug Profiling By Automated Microscopy , 2004, Science.

[58]  S. Schreiber,et al.  Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.

[59]  R N Kalaria,et al.  Microglia and Alzheimer's disease. , 1999, Current opinion in hematology.

[60]  S. Schreiber,et al.  Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus , 1991, Journal of protein chemistry.

[61]  Hee-Young Nam,et al.  The high throughput screening of neuropeptide FF2 receptor ligands from Korean herbal plant extracts , 2006, Peptides.

[62]  C. Pikaard,et al.  Gateway-compatible vectors for plant functional genomics and proteomics. , 2006, The Plant journal : for cell and molecular biology.

[63]  Yasuaki Shimizu,et al.  High-Throughput Screening of Low Molecular Weight NS3-NS4A Protease Inhibitors Using a Fluorescence Resonance Energy Transfer Substrate , 2005, Antiviral chemistry & chemotherapy.

[64]  L. Burdine,et al.  Target identification in chemical genetics: the (often) missing link. , 2004, Chemistry & biology.

[65]  L A Sklar,et al.  High throughput flow cytometry. , 2001, Cytometry.

[66]  Jiang Zhu,et al.  Functional characterization of cell lines for high-throughput screening of human neuromedin U receptor subtype 2 specific agonists using a luciferase reporter gene assay. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[67]  S A. Sundberg,et al.  Microchip-based systems for target validation and HTS. , 2000, Drug discovery today.

[68]  Wei Zheng,et al.  A Cell-Based Ultra-High-Throughput Screening Assay for Identifying Inhibitors of D-Amino Acid Oxidase , 2006, Journal of biomolecular screening.

[69]  Bernhard Schmidt,et al.  Role of microglia and host prion protein in neurotoxicity of a prion protein fragment , 1996, Nature.

[70]  Ira Pastan,et al.  Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Richard D. Ye,et al.  The Lysophospholipid Receptor G2A Activates a Specific Combination of G Proteins and Promotes Apoptosis* , 2003, The Journal of Biological Chemistry.

[72]  Matthew Bogyo,et al.  Using small molecules to dissect mechanisms of microbial pathogenesis. , 2009, ACS chemical biology.

[73]  Adam Yasgar,et al.  Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Schreiber,et al.  A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p , 1996, Science.

[75]  Polina Golland,et al.  Voronoi-Based Segmentation of Cells on Image Manifolds , 2005, CVBIA.

[76]  W. Wilcox,et al.  Simple, mammalian cell-based assay for identification of inhibitors of the Erk MAP kinase pathway , 2007, Investigational New Drugs.

[77]  Antoine Geissbühler,et al.  A Review of Content{Based Image Retrieval Systems in Medical Applications { Clinical Bene(cid:12)ts and Future Directions , 2022 .

[78]  Charles C Hong,et al.  Large-scale small-molecule screen using zebrafish embryos. , 2009, Methods in molecular biology.

[79]  Paul A. Viola,et al.  Boosting Image Retrieval , 2004, International Journal of Computer Vision.

[80]  J. C. Hinshaw,et al.  Discovering Modes of Action for Therapeutic Compounds Using a Genome-Wide Screen of Yeast Heterozygotes , 2004, Cell.

[81]  Andreas Sewing,et al.  Improving the Design and Analysis of High-Throughput Screening Technology Comparison Experiments Using Statistical Modeling , 2006, Journal of biomolecular screening.

[82]  Jason Donnelly,et al.  Adopting a Practical Statistical Approach for Evaluating Assay Agreement in Drug Discovery , 2005, Journal of biomolecular screening.

[83]  Todd R Golub,et al.  Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation , 2004, Nature Genetics.

[84]  M. Gore,et al.  Spectrophotometry & Spectrofluorimetry : a practical approach , 2000 .

[85]  Anne E Carpenter,et al.  High-throughput screen for novel antimicrobials using a whole animal infection model. , 2009, ACS chemical biology.

[86]  Maurizio Pellecchia,et al.  Systems-based design of bi-ligand inhibitors of oxidoreductases: filling the chemical proteomic toolbox. , 2004, Chemistry & biology.

[87]  Sung Ho Ryu,et al.  Differential activation of formyl peptide receptor signaling by peptide ligands. , 2003, Molecular pharmacology.

[88]  David E Root,et al.  Global analysis of large-scale chemical and biological experiments. , 2002, Current opinion in drug discovery & development.

[89]  Angela N Koehler,et al.  A method for the covalent capture and screening of diverse small molecules in a microarray format , 2006, Nature Protocols.

[90]  Nolan H. Sigal,et al.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin , 1989, Nature.

[91]  George G Harrigan,et al.  Photo-affinity labeling strategies in identifying the protein ligands of bioactive small molecules: examples of targeted synthesis of drug analog photoprobes. , 2004, Combinatorial chemistry & high throughput screening.

[92]  G. Superti-Furga,et al.  Target profiling of small molecules by chemical proteomics. , 2009, Nature chemical biology.

[93]  D. T. Yue,et al.  DsRed as a potential FRET partner with CFP and GFP. , 2003, Biophysical journal.

[94]  Robert Nadon,et al.  Statistical practice in high-throughput screening data analysis , 2006, Nature Biotechnology.

[95]  Christian N Parker,et al.  Characterization of a High-Throughput Screening Assay for Inhibitors of Elongation Factor P and Ribosomal Peptidyl Transferase Activity , 2006, Journal of biomolecular screening.

[96]  P. Wylie,et al.  Application of laser-scanning fluorescence microplate cytometry in high content screening. , 2006, Assay and drug development technologies.

[97]  Serene Josiah,et al.  Interpretation of uniform-well readouts. , 2009, Methods in molecular biology.

[98]  D. Speicher,et al.  Isolation and amino acid sequence of cyclophilin. , 1986, The Journal of biological chemistry.

[99]  John R. Proudfoot,et al.  Discovery and Development of Nevirapine , 2006 .

[100]  S. Haggarty,et al.  High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. , 1999, Chemistry & biology.

[101]  Andreas Sewing,et al.  Measuring intracellular calcium fluxes in high throughput mode. , 2003, Combinatorial chemistry & high throughput screening.

[102]  Michael I. Jordan,et al.  Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[103]  Sung Ho Ryu,et al.  Differential Activation of Formyl Peptide Receptor-Like 1 by Peptide Ligands 1 , 2003, The Journal of Immunology.

[104]  Anna E Speers,et al.  Profiling enzyme activities in vivo using click chemistry methods. , 2004, Chemistry & biology.

[105]  R. Hertzberg,et al.  High-throughput screening: new technology for the 21st century. , 2000, Current opinion in chemical biology.

[106]  Michel Roberge,et al.  Screening for chemical inhibitors of heterologous proteins expressed in yeast using a simple growth-restoration assay. , 2009, Methods in molecular biology.

[107]  Tudor I. Oprea,et al.  High-Throughput Screening with HyperCyt® Flow Cytometry to Detect Small Molecule Formylpeptide Receptor Ligands , 2005, Journal of biomolecular screening.

[108]  Steven A Carr,et al.  Identifying the proteins to which small-molecule probes and drugs bind in cells , 2009, Proceedings of the National Academy of Sciences.

[109]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[110]  H. Kolb,et al.  The growing impact of click chemistry on drug discovery. , 2003, Drug discovery today.

[111]  M. Allen,et al.  High Throughput Fluorescence Polarization: A Homogeneous Alternative to Radioligand Binding for Cell Surface Receptors , 2000, Journal of biomolecular screening.

[112]  Yosef Yarden,et al.  The Achilles Heel of ErbB-2/HER2: Regulation by the Hsp90 Chaperone Machine and Potential for Pharmacological Intervention , 2004, Cell cycle.

[113]  Annie L. Conery,et al.  Whole-animal high-throughput screens: the C. elegans model. , 2009, Methods in molecular biology.

[114]  Stuart L Schreiber,et al.  Small molecule modulation of the human chromatid decatenation checkpoint. , 2003, Chemistry & biology.

[115]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[116]  Carlos Arteaga,et al.  Targeting HER1/EGFR: a molecular approach to cancer therapy. , 2003, Seminars in oncology.

[117]  Jessica Friedman,et al.  A Kinase‐focused Compound Collection: Compilation and Screening Strategy , 2006, Chemical biology & drug design.

[118]  J Richard Archer,et al.  History, evolution, and trends in compound management for high throughput screening. , 2004, Assay and drug development technologies.

[119]  N. Ip,et al.  A reporter gene assay for the detection of phytoestrogens in traditional Chinese medicine , 2001, Phytotherapy research : PTR.

[120]  T. Golub,et al.  Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. , 2006, Cancer cell.

[121]  S. Schreiber,et al.  A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.

[122]  A. Coulson,et al.  A functional genomic analysis of cell morphology using RNA interference , 2003, Journal of biology.

[123]  Dustin J Maly,et al.  Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[124]  Seung Y Rhee,et al.  Systematic Analysis of Arabidopsis Organelles and a Protein Localization Database for Facilitating Fluorescent Tagging of Full-Length Arabidopsis Proteins1[W] , 2006, Plant Physiology.

[125]  Timothy J Mitchison,et al.  Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor. , 2005, Chemistry & biology.

[126]  Mark B. Carter,et al.  Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening. , 2007, Current opinion in pharmacology.

[127]  Susan M. Young,et al.  High-content screening: flow cytometry analysis. , 2009, Methods in molecular biology.

[128]  S. Haggarty,et al.  Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. , 1999, Science.

[129]  David E Root,et al.  Detecting Spatial Patterns in Biological Array Experiments , 2003, Journal of biomolecular screening.

[130]  David A. Cheresh,et al.  Recent advances in cell adhesion molecules and extracellular matrix proteins: potential clinical implications , 1997 .

[131]  R. Christopherson,et al.  Antibody arrays: an embryonic but rapidly growing technology. , 2002, Drug discovery today.

[132]  J. Geiser,et al.  Recombinational cloning vectors for regulated expression in Saccharomyces cerevisiae. , 2005, BioTechniques.

[133]  G. Gray,et al.  Targeted therapy for cancer: the HER-2/neu and Herceptin story. , 2003, Clinical leadership & management review : the journal of CLMA.

[134]  T. Kiefhaber,et al.  Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins , 1989, Nature.

[135]  Mihrimah Ozkan,et al.  Quantum dots and other nanoparticles: what can they offer to drug discovery? , 2004, Drug discovery today.

[136]  Bruce S Edwards,et al.  High‐throughput flow cytometry: Validation in microvolume bioassays , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[137]  S W Hell,et al.  EGFP and DsRed expressing cultures of Escherichia coli imaged by confocal, two‐photon and fluorescence lifetime microscopy , 2000, FEBS letters.

[138]  Brian J Eastwood,et al.  A Comparison of Assay Performance Measures in Screening Assays: Signal Window, Z' Factor, and Assay Variability Ratio , 2006, Journal of biomolecular screening.

[139]  N. Kuiper Tests concerning random points on a circle , 1960 .

[140]  Yosef Yarden,et al.  Hsp90 restrains ErbB‐2/HER2 signalling by limiting heterodimer formation , 2004, EMBO reports.

[141]  P. Clemons,et al.  Small molecules, big players: the National Cancer Institute's Initiative for Chemical Genetics. , 2006, Cancer research.

[142]  S. Haggarty,et al.  Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. , 2000, Chemistry & biology.

[143]  O. Shimomura,et al.  Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. , 1962, Journal of cellular and comparative physiology.

[144]  David Twell,et al.  Differential activation and conserved vegetative cell-specific activity of a late pollen promoter in species with bicellular and tricellular pollen , 1994 .

[145]  Jörg Hüser,et al.  A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide/cGMP pathway. , 2005, Analytical biochemistry.

[146]  S. Audétat,et al.  Yeast as a screening tool. , 2005, Drug discovery today. Technologies.

[147]  R. A. Leibler,et al.  On Information and Sufficiency , 1951 .

[148]  Anne E Carpenter Extracting rich information from images. , 2009, Methods in molecular biology.

[149]  David S. Lawrence,et al.  Bivalent Inhibitors of Protein Tyrosine Kinases , 1999 .

[150]  Norbert Perrimon,et al.  Parallel Chemical Genetic and Genome-Wide RNAi Screens Identify Cytokinesis Inhibitors and Targets , 2004, PLoS biology.

[151]  M Webb,et al.  Ultra-High Throughput Screen of Two-Million-Member Combinatorial Compound Collection in a Miniaturized, 1536-Well Assay Format , 2000, Journal of biomolecular screening.

[152]  W Frank An,et al.  Fluorescence-based assays. , 2009, Methods in molecular biology.